Aktuelle Urologie

LinksSchließen

Referenz

Rosenberg JE, Heath EI, O'Donnell PH. et al.
EV-201 Study: A single-arm, open-label, multicenter study of enfortumab vedotin for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor therapy.

J Clin Oncol 2018;
36
DOI: 10.1200/JCO.2018.36.15_suppl.TPS4590.

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: